Search Results - "Subong, E N"

Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial by Catalona, William J, Partin, Alan W, Slawin, Kevin M, Brawer, Michael K, Flanigan, Robert C, Patel, Anup, Richie, Jerome P, deKernion, Jean B, Walsh, Patrick C, Scardino, Peter T, Lange, Paul H, Subong, Eric N. P, Parson, Robert E, Gasior, Gail H, Loveland, Kathleen G, Southwick, Paula C

“…CONTEXT.— The percentage of free prostate-specific antigen (PSA) in serum has been shown to enhance the specificity of PSA testing for prostate cancer…”
Get full text

Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23 by Subong, Eric N.P., Shue, Matthew J., Epstein, Jonathan I., Briggman, Joseph V., Chan, Pui K., Partin, Alan W.

“…BACKGROUND The nuclear protein B23, nucleophosmin, is an RNA‐associated nucleolar phosphoprotein reported to be more abundant in malignant and growing cells…”
Get full text

Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis by Partin, A W, Criley, S R, Subong, E N, Zincke, H, Walsh, P C, Oesterling, J E

“…Age-specific prostate specific antigen (PSA) references ranges have been suggested to account for the age-dependent nature of the serum PSA concentration. It…”
Get more information

Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage by Lakshmanan, Y, Subong, E N, Partin, A W

“…Nuclear Matrix Proteins (NMP) have been shown to be tissue and cell-type specific. Several unique NMPs have been investigated in various cancerous tissues,…”
Get more information

Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia by Pannek, J, Marks, L S, Pearson, J D, Rittenhouse, H G, Chan, D W, Shery, E D, Gormley, G J, Subong, E N, Kelley, C A, Stoner, E, Partin, A W

“…Finasteride therapy for benign prostatic hyperplasia (BPH) results in a marked lowering of serum prostate specific antigen (PSA) levels. However, little is…”
Get more information

Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia by Marks, L S, Partin, A W, Gormley, G J, Dorey, F J, Shery, E D, Garris, J B, Subong, E N, Stoner, E, deKernion, J B

“…We sought to quantify prostate tissue changes induced by finasteride and to identify a predictor of finasteride response in men with symptomatic benign…”
Get more information

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer by Pannek, Jürgen, Rittenhouse, Harry G., Evans, Cindy L., Finlay, Judith A., Bruzek, Debra J., Cox, Jennifer L., Chan, Daniel W., Subong, Eric N.P., Partin, Alan W.

“…Abstract Prostate-specific antigen (PSA), a member of the human kallikrein (hK) family, is the most important tumor marker for early detection, staging, and…”
Get full text

Preliminary immunohistochemical characterization of a monoclonal antibody (pro:4-216) prepared from human prostate cancer nuclear matrix proteins by Partin, Alan W., Briggman, Joseph V., Subong, Eric N.P., Szaro, Robert, Oreper, Ana, Wiesbrock, Sarah, Meyer, Jane, Coffey, Donald S., Epstein, Jonathan I.

“…A nuclear matrix protein (PC-1) was previously identified and reported to be present only in human prostate cancer but absent in tissue from the same prostate…”
Get full text

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy by Partin, Alan W., Piantadosi, Steven, Subong, Eric N. P., Kelly, Cynthia A., Hortopan, Steven, Chan, Daniel W., Wolfert, Robert L., Rittenhouse, Harry G., Carter, H. Ballentine

“…BACKGROUND Our objective was to determine the clearance rate of free and total serum PSA following radical retropubic prostatectomy. METHODS Sera were obtained…”
Get full text

Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer: A Multi-institutional Update by Partin, Alan W, Kattan, Michael W, Subong, Eric N. P, Walsh, Patrick C, Wojno, Kirk J, Oesterling, Joseph E, Scardino, Peter T, Pearson, J. D

“…Objective.—To combine the clinical data from 3 academic institutions that serve as centers of excellence for the surgical treatment of clinically localized…”
Get full text

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age by Partin, Alan W., Catalona, William J., Southwick, Paula C., Subong, Eric N.P., Gasior, Gail H., Chan, Daniel W.

“…To determine whether the use of the free-to-total PSA ratio (percent free PSA) could increase the specificity of PSA testing for prostate cancer detection in…”
Get full text

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer by Pannek, Jürgen, Subong, Eric N.P., Jones, Kerrie A., Marschke, Penny L.S., Epstein, Jonathan I., Chan, Daniel W., Ballentine Carter, H., Luderer, Albert A., Partin, Alan W.

“…The combined use of total prostate-specific antigen (PSA), clinical stage, and Gleason score accurately predicts final pathologic stage for men with clinically…”
Get full text

Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer by Partin, A W, Brawer, M K, Subong, E N P, Kelley, C A, Cox, J L, Bruzek, D J, Pannek, J, Meyer, G E, Chan, D W

“…Aims of the study: Retrospective studies investigating the use of percent free-PSA for early detection of prostate cancer were limited for various reasons: by…”
Get full text

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection : Influence of total PSA, prostate volume, and age: The clinical usefulness of percent free prostate-specific antigen by PARTIN, A. W, CATALONA, W. J, SOUTHWICK, P. C, SUBONG, E. N. P, GASIOR, G. H, CHAN, D. W

Get full text

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer: The clinical usefulness of percent free prostate-specific antigen by PANNEK, J, SUBONG, E. N. P, JONES, K. A, MARSCHKE, P. L. S, EPSTEIN, J. I, CHAN, D. W, BALLENTINE CARTER, H, LUDERER, A. A, PARTIN, A. W

Get full text

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer--a multi-institutional update by Graefen, Markus

Get more information